by Matthew Johnson | Nov 17, 2025 | District Court, Federal Circuit Appeal, PTAB News, PTAB Trial Basics, Trial Institution
By Thane Bonnett,* Daniel Sloan, and Matt Johnson – On October 17, 2025, the USPTO issued a notice of proposed rulemaking (“Notice”) regarding the rules of practice for inter partes review before the PTAB. The proposed rules do not apply to post grant review...
by Matthew Johnson | Nov 4, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Adam J. Cook, Daniel C. Sloan, and Matt Johnson – The October 17 Memo from Director Squires marked the end of a distinct discretionary denial era, the Interim Era. Per the memo, as of October 20, all institution decisions (discretionary, non-discretionary,...
by Matthew Johnson | Nov 3, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Matt Johnson – On October 31st, the Director issued his first set of summary decisions on IPR institutions, denying institution of 13 cases without comment in a single...
by Matthew Johnson | Oct 30, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Adam Cook, Christian Roberts, and Matt Johnson – On October 29th, Acting Chief Judge Deshpande and Vice Chief Judge Kim discussed Director institution of AIA trials, where the Director will make all institution decisions (on both discretionary,...
by Matthew Johnson | Oct 29, 2025 | Claim Construction, PTAB News, PTAB Trial Basics, Trial Institution
By Evan Tassis and Matt Johnson – In a recent decision, Acting Director Coke Morgan Stewart granted Patent Owner’s request for discretionary denial in Sun Pharmaceuticals Industries Inc. v. Nivagen Pharmaceuticals, Inc., IPR2025-00893. While some factors...
